[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5731 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 5731

 To direct the Secretary of Defense to report on illicit drug use and 
    overdoses by members of the Armed Forces serving on active duty.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 26, 2023

   Mr. Ryan introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
 To direct the Secretary of Defense to report on illicit drug use and 
    overdoses by members of the Armed Forces serving on active duty.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REPORT ON ILLICIT DRUG USE AND OVERDOSES BY MEMBERS OF THE 
              ARMED FORCES SERVING ON ACTIVE DUTY.

    Not later than December 1, 2023, the Secretary of Defense shall 
submit to the Committees on Armed Services of the Senate and House of 
Representatives a report regarding illicit drug use by members of the 
Armed Forces serving on active duty, and monitoring and prevention 
systems within the Department of Defense regarding such use. The report 
shall include the following elements:
            (1) The number of instances of such drug use and overdoses 
        among such members during the calendar year preceding the date 
        of the report.
            (2) The number of instances described in paragraph (1) that 
        were related to fentanyl.
            (3) An explanation of how the Secretary uses urinalysis and 
        other tests to monitor such use, and an assessment of the 
        efficacy of such tests.
            (4) The extent to which fentanyl has contributed to such 
        overdoses when combined with other, less deadly substances.
            (5) The policies of the Department designed to prevent 
        retaliation against such members who seek treatment or inform a 
        commanding officer of their illicit drug use.
            (6) Demographic data and ranks of such members who suffered 
        a fentanyl overdose.
            (7) Shortcomings (including strategic or budgetary) 
        identified by the Secretary of the counternarcotics programs of 
        the Department regarding military installations.
            (8) A thorough review of the support and treatment options 
        offered to such a member who reports addiction or illicit drug 
        use, including--
                    (A) any wait time before receiving care; and
                    (B) the type of care offered across each Armed 
                Force.
            (9) Any other matter the Secretary determines appropriate.
                                 <all>